Fetzima
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box 7017, Bedminster, New Jersey, 079...Website
www.fetzima.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Fetzima
FETZIMA is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of Major Depressive Disorder (MDD). The recommended therapeutic dose range for FETZIMA is 40 mg to 120 mg once daily and can be taken with or without food. While the exact mechanism is unknown, it is thought to be related to the potentiation of serotonin and norepinephrine in the central nervous system, through inhibition of reuptake at serotonin and norepinephrine transporters. Non-clinical studies have shown that FETZIMA is a potent and selective serotonin and norepinephrine reuptake inhibitor. Levomilnacipran was licensed to Forest Laboratories Inc. by Pierre Fabre, in the U.S. and Canada. Pierre-Fabre will also be the active pharmaceutical ingredient (API) supplier.Explore more
Popular SearchesFetzimaAbbVie IncSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Fetzima your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Fetzima
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Fetzima had a recent Job posting/layoffs
Product Launch: Get notified when Fetzima launches new products
Check out if Fetzima is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Fetzima recently announced quarterly report
Check if Fetzima has recently received funding, and reach out quickly before it becomes old news!
Fetzima, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Fetzima has new funding data
Recommended Actions
Find VP level buyers at Fetzima
Find 3 more new buyers
Compare Similar Companies to Fetzima
Compare insights from companies similar to Fetzima, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Fetzima
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Fetzima is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Fetzima is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Fetzima.
Fetzima Tech Stack
A closer look at the technologies used by Fetzima
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Fetzima
Sign Up For FreeTo access detailed company insights
FETZIMA is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of Major Depressive Disorder (MDD). The recommended therapeutic dose range for FETZIMA is 40 mg to 120 mg once daily and can be taken with or without food. While the exact mechanism is unknown, it is thought to be related to the potentiation of serotonin... Read More
